ANTIHYPERTENSIVE ACTIVITY OF N-[(S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL]-L-ALA-L-PRO (MK-421), AN ORALLY ACTIVE CONVERTING ENZYME-INHIBITOR
- 1 January 1981
- journal article
- research article
- Vol. 216 (3), 558-566
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Evidence for the Local Occurrence of Angiotensin II in Rat Kidney and its Modulation by Dietary Sodium Intake and Converting Enzyme BlockadeClinical Science, 1979
- Cardiovascular properties of antihypertensive drugs in a model of severe renal hypertensionJournal of Pharmacological Methods, 1979
- Effects of an Orally Active Converting-Enzyme Inhibitor, SQ 14225, on Pressor Responses to Angiotensin Administered into the Brain Ventricles of Spontaneously Hypertensive RatsClinical Science, 1979
- Effects of continuous converting enzyme blockade on renovascular hypertension in the ratAmerican Journal of Physiology-Renal Physiology, 1979
- EFFECTS OF CHRONIC TREATMENT WITH CAPTOPRIL(SQ 14,225), AN ORALLY ACTIVE INHIBITOR OFANGIOTENSIN I-CONVERTING ENZYME, INSPONTANEOUSLY HYPERTENSIVE RATSThe Japanese Journal of Pharmacology, 1979
- Long-Term Efficacy of Captopril (SQ 14,225) In 2-Kidney Renal Hypertensive RatsClinical and Experimental Hypertension, 1978
- Antihypertensive Effect of the Oral Angiotensin Converting-Enzyme Inhibitor SQ 14225 in ManNew England Journal of Medicine, 1978
- SQ 14,225 (D-3-MERCAPTO-2-METHYLPROPANOYL-L-PROLINE), A NOVEL ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN I-CONVERTING ENZYME1978
- ANTIHYPERTENSIVE ACTIVITY IN RATS OF SQ 14,225, AN ORALLY ACTIVE INHIBITOR OF ANGIOTENSIN I-CONVERTING ENZYME1978
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977